Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School

Generated: December 16, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2005-312076

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Viiv HlthcareTIVICAYdolutegravir sodiumTABLET;ORAL204790-001Aug 12, 2013RXYesYes► Subscribe► SubscribeYY
Viiv HlthcareTIVICAYdolutegravir sodiumTABLET;ORAL204790-002Jun 9, 2016RXYesNo► Subscribe► SubscribeYY
Viiv HlthcareTIVICAYdolutegravir sodiumTABLET;ORAL204790-003Jun 9, 2016RXYesNo► Subscribe► SubscribeYY
Viiv HlthcareTRIUMEQabacavir sulfate; dolutegravir sodium; lamivudineTABLET;ORAL205551-001Aug 22, 2014RXYesYes► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist